Kansas City Parents Confront NextGen COVID Vaxx Decision

The choice over giving the COVID vaxx to youngsters is tough and we don't envy the decision confronting conscientious adults.

However . . .


Given that the contents of "chicken nuggets" are just as scary as anything cooked up by Big Pharma . . . It's important to have appropriate benchmarks in this conversation about public health. And so, as a public service, TKC offers this counterpoint to throw at family & frenemies as this discussion hits home and will spark worsening debate amongst loved ones.

Read more via www.TonysKansasCity.com news links . . .

Covid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says

A Phase 2/3 trial of Pfizer/BioNTech's two-dose Covid-19 vaccine for children ages 5 to 11 showed it is safe and generated a "robust" antibody response.

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon -- a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older.

Kansas City-area parents waiting for vaccine for kids 'encouraged' by Pfizer announcement

KANSAS CITY, Mo. - Following Pfizer's announcement that its vaccine trials for children ages five through 11 showed positive results, KSHB 41 News spoke with parents in the Kansas City area. Parents we talked to said they felt encouraged and that it gives them some peace of mind going forward.

Metro health experts weigh in after Pfizer says COVID-19 vaccine works on children ages 5 to 11

KANSAS CITY, Mo. - Health experts say there's a possibility kids ages 5 to 11 could get the COVID-19 vaccine around Halloween. This comes after Pfizer announced its data shows the vaccine works well for children in that age group, so now it needs FDA approval.

Kansas City-area pediatrician excited, hopeful following initial Pfizer vaccine findings

KANSAS CITY, Mo. - Pfizer announced the initial findings about the safety of its COVID-19 vaccine for children ages five to 11 Monday. In a news release, the company said its phase 2/3 trial showed the vaccine was safe and produced a robust immune response.

Developing . . .